⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6337301 | 0.93 | — | — | |
| SCHEMBL6334987 | 0.91 | — | — | |
| SCHEMBL6335223 | 0.90 | — | — | |
| SCHEMBL6335120 | 0.88 | — | — | |
| SCHEMBL14489619 | 0.84 | — | — | |
| SCHEMBL28678678 | 0.83 | HDAC6 (0.73) | — | |
| SCHEMBL6343788 | 0.83 | — | — | |
| SCHEMBL28689650 | 0.83 | — | — | |
| SCHEMBL6335541 | 0.82 | — | — | |
| SCHEMBL30583153 | 0.82 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6964970-B2 | Antibacterial compounds | AFFINIUM PHARMACEUTICALS, INC. (CA) | 2005-11-15 | — | — | US | claimed |
| EP-1180030-B1 | ANTIBACTERIAL COMPOUNDS | AFFINIUM PHARM INC (CA) | 2004-11-24 | — | — | EP | claimed |
| US-20030232850-A1 | Antibacterial compounds | DEBIOPHARM INTERNATIONAL SA (CH) | 2003-12-18 | — | — | US | claimed |
| US-6964970-B2 | Antibacterial compounds | AFFINIUM PHARMACEUTICALS, INC. (CA) | 2005-11-15 | — | — | US | disclosed |
| EP-1180030-B1 | ANTIBACTERIAL COMPOUNDS | AFFINIUM PHARM INC (CA) | 2004-11-24 | — | — | EP | disclosed |
| US-20030232850-A1 | Antibacterial compounds | DEBIOPHARM INTERNATIONAL SA (CH) | 2003-12-18 | — | — | US | disclosed |
| US-6573272-B1 | Antibacterial compounds | AFFINIUM PHARMACEUTICALS, INC. (CA) | 2003-06-03 | — | — | US | disclosed |